Diligence memo · auto-generated · as of July 2, 2026
ISI Life Sciences, Inc.
ISI Life Sciences, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
ISI Life Sciences, Inc. operates in Biotechnology, based in NEWPORT BEACH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
ISI Life Sciences, Inc. has raised $354K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $354K on 2012-12-17.
Most recent recorded round closed around 2012-12-17.
Valuation (modeled)modeled
Provath models ISI Life Sciences, Inc. at approximately $20M (range $189K–$222M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.00× the median modeled value of Pre-Seed Biotechnology companies in 2010–2012 (132 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 13.5 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 8% of Biotechnology peers (4293 compared).
Modeled value ranks above 28% of those peers.
Closest niche peers: Hygeia Therapeutics, Inc., Act Biotech Inc, Ikonopedia, LLC, Iquum Inc, Koronis Pharma, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.